MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin
Yihui Wen(University of Pittsburgh), Jennifer R. Grandis(University of California, San Francisco)
Cited by 10
Related Papers
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer
|Nature Genetics|2016|252
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
|Journal of Clinical Investigation|2015|200